《全日速報》恆指升224點; 恆生科技指數升67點 平安升逾3% 聯通、新東方在線、康諾亞-B、先聲藥業、海吉亞醫療創新高 成交暢旺
恆指全日收21,738點,升224點或1.0%。恆生科技指數報4,554點,升67點或1.5%。國指升79點或1.1%,報7,391點。大市成交額1,330.11億元。
活躍重磅股表現:
平安(02318.HK) 收62.15元,上升3.6%;
騰訊(00700.HK) 收371.4元,上升2%;
阿里巴巴(09988.HK) 收112.7元,上升1.7%;
美團(03690.HK) 收171.2元,下跌1%;
建行(00939.HK) 收5.06元,上升1%;
友邦(01299.HK) 收87.95元,下跌0.5%;
港交所(00388.HK) 收368.8元,下跌0.4%;
異動恆指及國指成份股:
藥明生物(02269.HK) 收72.6元,上升6.4%;
周大福(01929.HK) 收17.5元,上升4.8%;
網易(09999.HK) 收136.9元,上升4.7%;
信義光能(00968.HK) 收9.79元,下跌4.4%;
中生製藥(01177.HK) 收4.99元,上升3.7%;
阿里健康(00241.HK) 收7.59元,上升3.7%;
京東健康(06618.HK) 收69.25元,上升3.6%;
聯通(00762.HK) 收5.35元,上升1.5%,創新高;
異動綜合中小型股:
新東方在線(01797.HK) 收69.35元,上升15.2%,創新高;
諾輝健康(06606.HK) 收30.3元,上升14.3%;
心通醫療(02160.HK) 收3.5元,上升14%;
科濟藥業-B(02171.HK) 收19.9元,上升13.2%;
沛嘉醫療(09996.HK) 收11.72元,上升12.7%;
微創機器人-B(02252.HK) 收36.2元,上升12.6%;
錦欣生殖(01951.HK) 收7.65元,上升12.5%;
榮昌生物-B(09995.HK) 收67.8元,上升11.8%;
瑞爾集團(06639.HK) 收10.46元,上升11.4%;
騰盛博藥-B(02137.HK) 收8.91元,上升11%;
啟明醫療(02500.HK) 收17.18元,上升10.8%;
寶尊電商-W(09991.HK) 收19.22元,上升10.3%;
康諾亞-B(02162.HK) 收67.2元,上升10%,創新高;
先聲藥業(02096.HK) 收13.66元,上升8.4%,創新高;
海吉亞醫療(06078.HK) 收63.7元,上升8.1%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.